261 related articles for article (PubMed ID: 20634176)
1. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
[TBL] [Abstract][Full Text] [Related]
2. Initial combination therapy with metformin and colesevelam for achievement of glycemic and lipid goals in early type 2 diabetes.
Rosenstock J; Fonseca VA; Garvey WT; Goldberg RB; Handelsman Y; Abby SL; Lai YL; Jin X; Misir S; Nagendran S; Jones MR
Endocr Pract; 2010; 16(4):629-40. PubMed ID: 20634175
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of colesevelam in Hispanic subjects with primary hyperlipidemia and prediabetes.
Rosenstock J; Hernandez-Triana E; Handelsman Y; Misir S; Jones MR
Postgrad Med; 2012 Jul; 124(4):14-20. PubMed ID: 22913890
[TBL] [Abstract][Full Text] [Related]
4. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
Bays HE
Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
[TBL] [Abstract][Full Text] [Related]
5. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
[TBL] [Abstract][Full Text] [Related]
6. Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus.
Goldberg RB; Rosenson RS; Hernandez-Triana E; Misir S; Jones MR
J Clin Lipidol; 2012; 6(4):318-24. PubMed ID: 22836068
[TBL] [Abstract][Full Text] [Related]
7. A 50-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia.
Davidson MH; Donovan JM; Misir S; Jones MR
Am J Cardiovasc Drugs; 2010; 10(5):305-14. PubMed ID: 20860413
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
[TBL] [Abstract][Full Text] [Related]
9. Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes.
Handelsman Y; Abby SL; Jin X; Donovan JM; Jones MR
Postgrad Med; 2009 Nov; 121(6):62-9. PubMed ID: 19940418
[TBL] [Abstract][Full Text] [Related]
10. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Bays HE; Goldberg RB; Truitt KE; Jones MR
Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
[TBL] [Abstract][Full Text] [Related]
11. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of colesevelam hydrochloride in decreasing LDL cholesterol in patients with primary hypercholesterolemia: a 24-week randomized controlled trial.
Insull W; Toth P; Mullican W; Hunninghake D; Burke S; Donovan JM; Davidson MH
Mayo Clin Proc; 2001 Oct; 76(10):971-82. PubMed ID: 11605698
[TBL] [Abstract][Full Text] [Related]
13. Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.
Vega GL; Dunn FL; Grundy SM
Am J Cardiol; 2011 Oct; 108(8):1129-35. PubMed ID: 21813109
[TBL] [Abstract][Full Text] [Related]
14. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
15. Colesevelam hydrochloride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects.
Davidson MH; Dillon MA; Gordon B; Jones P; Samuels J; Weiss S; Isaacsohn J; Toth P; Burke SK
Arch Intern Med; 1999 Sep; 159(16):1893-900. PubMed ID: 10493319
[TBL] [Abstract][Full Text] [Related]
16. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
18. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.
Henry RR; Aroda VR; Mudaliar S; Garvey WT; Chou HS; Jones MR
Diabetes Obes Metab; 2012 Jan; 14(1):40-6. PubMed ID: 21831167
[TBL] [Abstract][Full Text] [Related]
19. Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.
Stein EA; Marais AD; Szamosi T; Raal FJ; Schurr D; Urbina EM; Hopkins PN; Karki S; Xu J; Misir S; Melino M
J Pediatr; 2010 Feb; 156(2):231-6.e1-3. PubMed ID: 19879596
[TBL] [Abstract][Full Text] [Related]
20. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
Handelsman Y
Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
